The absence of Tregs correlates with the locally decreased expression of CXCL12, suggesting that improved function of the CXCL12/CXCR4 axis and subsequent retention of Tregs in the PLNs could serve as the basis for an alternative therapeutic approach for treating T1D. This evidence concerns the gene CXCL12 and type 1 diabetes mellitus.